• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study.异基因造血干细胞移植术后眼表病变的相关因素:一项回顾性研究。
Front Oncol. 2022 Nov 21;12:1040679. doi: 10.3389/fonc.2022.1040679. eCollection 2022.
2
[Clinical characteristics and correlative factors of dry eye disease associated with graft-versus-host disease].移植物抗宿主病相关干眼的临床特征及相关因素
Zhonghua Yan Ke Za Zhi. 2023 Apr 11;59(4):295-301. doi: 10.3760/cma.j.cn112142-20220801-00370.
3
Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.印度一家三级医疗中心同种异体造血干细胞移植中的眼部移植物抗宿主病
Indian J Med Res. 2015 Nov;142(5):543-8. doi: 10.4103/0971-5916.171280.
4
Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后眼部移植物抗宿主病症状的发作。
Cornea. 2015 Mar;34(3):243-7. doi: 10.1097/ICO.0000000000000340.
5
A plethora of ocular surface manifestations in a multidisciplinary ocular graft-versus-host disease unit.多学科眼移植物抗宿主病单位中的大量眼部表面表现。
Sci Rep. 2022 Sep 23;12(1):15926. doi: 10.1038/s41598-022-19990-z.
6
Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.临床前异基因造血干细胞移植动物模型中眼部移植物抗宿主病评估的新型评分标准
Biol Blood Marrow Transplant. 2016 Oct;22(10):1765-1772. doi: 10.1016/j.bbmt.2016.07.012. Epub 2016 Aug 1.
7
Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients.异基因造血干细胞移植患者的眼表评估
Eur J Ophthalmol. 2014 Sep-Oct;24(5):655-66. doi: 10.5301/ejo.5000451. Epub 2014 Mar 7.
8
Single-Center Retrospective Study on Meibomian Gland Loss in Patients With Ocular Chronic Graft-Versus-Host Disease.单中心回顾性研究:眼部慢性移植物抗宿主病患者的睑板腺损失情况
Eye Contact Lens. 2018 Nov;44 Suppl 2:S169-S175. doi: 10.1097/ICL.0000000000000445.
9
Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.异基因造血干细胞移植前后血液病患者的眼表分析:对日常临床实践的启示
Eye (Lond). 2017 Oct;31(10):1417-1426. doi: 10.1038/eye.2017.78. Epub 2017 May 19.
10
Changes of meibomian glands in the early stage of post hematopoietic stem cell transplantation.造血干细胞移植术后早期睑板腺的变化
Exp Eye Res. 2017 Oct;163:85-90. doi: 10.1016/j.exer.2017.07.013. Epub 2017 Jul 21.

引用本文的文献

1
Risk factors for ocular graft-versus-host disease: A systematic review and meta-analysis.眼部移植物抗宿主病的危险因素:一项系统评价与荟萃分析。
PLoS One. 2025 Jun 5;20(6):e0324703. doi: 10.1371/journal.pone.0324703. eCollection 2025.

本文引用的文献

1
T-Cell Metabolism in Graft Host Disease.移植物抗宿主病中的 T 细胞代谢。
Front Immunol. 2021 Oct 29;12:760008. doi: 10.3389/fimmu.2021.760008. eCollection 2021.
2
Keeping an 'eye' on ocular GVHD.密切关注眼部移植物抗宿主病
Clin Exp Optom. 2022 Mar;105(2):135-142. doi: 10.1080/08164622.2021.1971047. Epub 2021 Sep 19.
3
A Review of Ocular Graft-versus-Host Disease: Pathophysiology, Clinical Presentation and Management.眼移植物抗宿主病的研究进展:发病机制、临床表现与治疗。
Ocul Immunol Inflamm. 2021 Aug 18;29(6):1190-1199. doi: 10.1080/09273948.2021.1939390. Epub 2021 Jul 6.
4
Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG.与未使用抗胸腺细胞球蛋白(ATG)的匹配亲缘供者相比,使用 ATG 的匹配无关供者造血干细胞移植可实现更好的移植物抗宿主病无复发生存率。
Transplant Cell Ther. 2021 Jul;27(7):621.e1-621.e3. doi: 10.1016/j.jtct.2021.03.019. Epub 2021 Mar 24.
5
Prevalence and Risk Factors Associated With Corneal Perforation in Chronic Ocular Graft-Versus-Host-Disease.慢性眼部移植物抗宿主病中角膜穿孔的患病率及相关危险因素
Cornea. 2021 Jul 1;40(7):877-882. doi: 10.1097/ICO.0000000000002526.
6
Metabolic Pathways in Alloreactive T Cells.同种反应性 T 细胞中的代谢途径。
Front Immunol. 2020 Jul 24;11:1517. doi: 10.3389/fimmu.2020.01517. eCollection 2020.
7
Unrelated Donor Transplant Recipients Given Thymoglobuline Have Superior GRFS When Compared to Matched Related Donor Recipients Undergoing Transplantation without ATG.与未用 ATG 的匹配相关供者移植受者相比,接受胸腺球蛋白的无关供者移植受者具有更好的 GRFS。
Biol Blood Marrow Transplant. 2020 Oct;26(10):1868-1875. doi: 10.1016/j.bbmt.2020.06.030. Epub 2020 Jul 5.
8
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.来自HLA匹配供者和替代供者的异基因造血干细胞移植的结局:欧洲血液与骨髓移植学会登记处的回顾性分析
Lancet Haematol. 2019 Nov;6(11):e573-e584. doi: 10.1016/S2352-3026(19)30158-9. Epub 2019 Aug 30.
9
Corneal fluorescein staining and ocular symptoms but not Schirmer test are useful as indicators of response to treatment in chronic ocular GVHD.角膜荧光素染色和眼部症状而非 Schirmer 试验可作为慢性眼部移植物抗宿主病治疗反应的有用指标。
Ocul Surf. 2018 Jul;16(3):377-381. doi: 10.1016/j.jtos.2018.05.002. Epub 2018 May 19.
10
Ocular Surface and Tear Film Characteristics in a Sclerodermatous Chronic Graft-Versus-Host Disease Mouse Model.硬皮病慢性移植物抗宿主病小鼠模型的眼表和泪膜特征
Cornea. 2018 Apr;37(4):486-494. doi: 10.1097/ICO.0000000000001487.

异基因造血干细胞移植术后眼表病变的相关因素:一项回顾性研究。

Correlative factors of ocular surface lesions after allogeneic hematopoietic stem cell transplantation: A retrospective study.

作者信息

Zhuang Xin-Yu, Sun Zheng-Tai, Xu Yue, Ren Ya-Ru, Chen Ying-Jie, Chen Feng, Ma Xiao, Tang Xiao-Wen, Zhang Xiao-Feng

机构信息

Department of Ophthalmology, First Affiliated Hospital of Soochow University, Suzhou, China.

Department of Ophthalmology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China.

出版信息

Front Oncol. 2022 Nov 21;12:1040679. doi: 10.3389/fonc.2022.1040679. eCollection 2022.

DOI:10.3389/fonc.2022.1040679
PMID:36479063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9719980/
Abstract

BACKGROUND

Ocular graft-versus-host disease (oGVHD) is one of the complications after allogeneic hematopoietic stem cell transplantation (HSCT), which impairs the quality of life and may indicate poor prognosis. In this retrospective study, the aim was to investigate the characteristics of ocular surface after HSCT, and analyze the risk factors related to the severity of ocular surface lesions.

METHODS

248 post-HSCT patients were enrolled in this retrospective study. Subjects were divided into no lesion group, mild lesion group and severe lesion group, according to the severity of ocular surface lesions. The correlations between grades of ocular surface lesions and gender, age, primary disease, donor source, human leukocyte antigen (HLA) type, kinship, donor-recipient relationship, blood type, source of stem cell and systemic GVHD were analyzed.

RESULTS

The median scores of corneal epitheliopathy, lid margin lesions and meibomian gland loss were 3, 6 and 2 points, respectively. The grade of corneal epitheliopathy was related to donor source (P<0.001), kinship (P=0.033), HLA-matching (P<0.001), and systemic GVHD (P=0.007), especially oral GVHD (P<0.001) and liver GVHD (P=0.002). The grade of lid margin lesions was related to donor source (P=0.019), HLA-matching (P=0.006), and systemic GVHD (P=0.013), especially skin GVHD (P=0.019) and oral GVHD (P=0.019). The grade of meibomian gland loss was related to age (P=0.035) and gastrointestinal GVHD (P=0.007). The grade of corneal epitheliopathy after HSCT was related to the lid margin lesion score (P<0.001).

CONCLUSIONS

The occurrence and development of ocular GVHD are mostly accompanied by the history of systemic GVHD. While in few cases, ocular surface lesions related to GVHD can be observed prior to the rejection of other tissues and organs. Severe corneal epitheliopathy occurs in patients with severe lid margin lesions in ocular GVHD. The lesions of corneal epithelium and lid margin are milder in HLA partially matching transplantation.

摘要

背景

眼部移植物抗宿主病(oGVHD)是异基因造血干细胞移植(HSCT)后的并发症之一,会损害生活质量,且可能预示预后不良。在这项回顾性研究中,目的是调查HSCT后眼表的特征,并分析与眼表病变严重程度相关的危险因素。

方法

248例HSCT后患者纳入这项回顾性研究。根据眼表病变的严重程度,将受试者分为无病变组、轻度病变组和重度病变组。分析眼表病变分级与性别、年龄、原发病、供体来源、人类白细胞抗原(HLA)类型、亲缘关系、供受者关系、血型、干细胞来源和系统性GVHD之间的相关性。

结果

角膜上皮病变、睑缘病变和睑板腺缺失的中位数评分分别为3分、6分和2分。角膜上皮病变的分级与供体来源(P<0.001)、亲缘关系(P=0.033)、HLA匹配(P<0.001)和系统性GVHD(P=0.007)有关,尤其是口腔GVHD(P<0.001)和肝脏GVHD(P=0.002)。睑缘病变的分级与供体来源(P=0.019)、HLA匹配(P=0.006)和系统性GVHD(P=0.013)有关,尤其是皮肤GVHD(P=0.019)和口腔GVHD(P=0.019)。睑板腺缺失的分级与年龄(P=0.035)和胃肠道GVHD(P=0.007)有关。HSCT后角膜上皮病变的分级与睑缘病变评分有关(P<0.001)。

结论

眼部GVHD的发生和发展大多伴有系统性GVHD病史。而在少数情况下,与GVHD相关的眼表病变可在其他组织和器官发生排斥之前被观察到。眼部GVHD中,严重睑缘病变的患者会出现严重的角膜上皮病变。在HLA部分匹配移植中,角膜上皮和睑缘的病变较轻。